Abstract:ObjectiveThis study aimed to establish a combined radiomics nomogram to preoperatively predict the risk categorization of thymomas by using contrast-enhanced computed tomography (CE-CT) images.Materials and MethodsThe clinical, pathological, and CT data of 110 patients with thymoma (50 patients with low-risk thymomas and 60 patients with high-risk thymomas) collected in our Hospital from July 2017 to March 2022 were retrospectively analyzed. The study subjects were randomly divided into the training set (n = 7… Show more
“…They were all published in the recent three years, with nearly half of them published in the last years (2022). Except for three studies from Switzerland, Japan and the United States [ 22 , 25 , 28 ], the other studies all came from different provinces of China [ 16 – 21 , 23 , 24 , 26 , 27 ]. This might be related to the low incidence of TETs and the difficulty of conducting multi-center radiomics studies.…”
Section: Discussionmentioning
confidence: 99%
“…Several non-radiomics indicators were included in the clinical combined radiomics models, such as, gender, age, myasthenia gravis and regular imaging findings (tumor size, pleural effusion, pericardial effusion, infiltration, etc.) [ 18 , 19 , 21 , 23 ]. Although there was no statistical difference between the combined model and the radiomics model in the prediction efficiency, the absolute values were all improved in the studies.…”
Background
Incidental thymus region masses during thoracic examinations are not uncommon. The clinician’s decision-making for treatment largely depends on imaging findings. Due to the lack of specific indicators, it may be of great value to explore the role of radiomics in risk categorization of the thymic epithelial tumors (TETs).
Methods
Four databases (PubMed, Web of Science, EMBASE and the Cochrane Library) were screened to identify eligible articles reporting radiomics models of diagnostic performance for risk categorization in TETs patients. The quality assessment of diagnostic accuracy studies 2 (QUADAS-2) and radiomics quality score (RQS) were used for methodological quality assessment. The pooled area under the receiver operating characteristic curve (AUC), sensitivity and specificity with their 95% confidence intervals were calculated.
Results
A total of 2134 patients in 13 studies were included in this meta-analysis. The pooled AUC of 11 studies reporting high/low-risk histologic subtypes was 0.855 (95% CI, 0.817–0.893), while the pooled AUC of 4 studies differentiating stage classification was 0.826 (95% CI, 0.817–0.893). Meta-regression revealed no source of significant heterogeneity. Subgroup analysis demonstrated that the best diagnostic imaging was contrast enhanced computer tomography (CECT) with largest pooled AUC (0.873, 95% CI 0.832–0.914). Publication bias was found to be no significance by Deeks’ funnel plot.
Conclusions
This present study shows promise for preoperative selection of high-risk TETs patients based on radiomics signatures with current available evidence. However, methodological quality in further studies still needs to be improved for feasibility confirmation and clinical application of radiomics-based models in predicting risk categorization of the thymic epithelial tumors.
“…They were all published in the recent three years, with nearly half of them published in the last years (2022). Except for three studies from Switzerland, Japan and the United States [ 22 , 25 , 28 ], the other studies all came from different provinces of China [ 16 – 21 , 23 , 24 , 26 , 27 ]. This might be related to the low incidence of TETs and the difficulty of conducting multi-center radiomics studies.…”
Section: Discussionmentioning
confidence: 99%
“…Several non-radiomics indicators were included in the clinical combined radiomics models, such as, gender, age, myasthenia gravis and regular imaging findings (tumor size, pleural effusion, pericardial effusion, infiltration, etc.) [ 18 , 19 , 21 , 23 ]. Although there was no statistical difference between the combined model and the radiomics model in the prediction efficiency, the absolute values were all improved in the studies.…”
Background
Incidental thymus region masses during thoracic examinations are not uncommon. The clinician’s decision-making for treatment largely depends on imaging findings. Due to the lack of specific indicators, it may be of great value to explore the role of radiomics in risk categorization of the thymic epithelial tumors (TETs).
Methods
Four databases (PubMed, Web of Science, EMBASE and the Cochrane Library) were screened to identify eligible articles reporting radiomics models of diagnostic performance for risk categorization in TETs patients. The quality assessment of diagnostic accuracy studies 2 (QUADAS-2) and radiomics quality score (RQS) were used for methodological quality assessment. The pooled area under the receiver operating characteristic curve (AUC), sensitivity and specificity with their 95% confidence intervals were calculated.
Results
A total of 2134 patients in 13 studies were included in this meta-analysis. The pooled AUC of 11 studies reporting high/low-risk histologic subtypes was 0.855 (95% CI, 0.817–0.893), while the pooled AUC of 4 studies differentiating stage classification was 0.826 (95% CI, 0.817–0.893). Meta-regression revealed no source of significant heterogeneity. Subgroup analysis demonstrated that the best diagnostic imaging was contrast enhanced computer tomography (CECT) with largest pooled AUC (0.873, 95% CI 0.832–0.914). Publication bias was found to be no significance by Deeks’ funnel plot.
Conclusions
This present study shows promise for preoperative selection of high-risk TETs patients based on radiomics signatures with current available evidence. However, methodological quality in further studies still needs to be improved for feasibility confirmation and clinical application of radiomics-based models in predicting risk categorization of the thymic epithelial tumors.
“…Linear correlation between each feature and the category label was evaluated through the optimal feature filter, and the 45 most relevant features from the 1,781 features were selected. The LASSO algorithm was used to select the most relevant feature from the 45 features ( 20 ) ( Figure 4 ). Finally, we selected a total of 15 most relevant features for the pathological grade of BCa ( Figure 5 ).…”
ObjectiveThe purpose of this research was to develop a radiomics model that combines several clinical features for preoperative prediction of the pathological grade of bladder cancer (BCa) using non-enhanced computed tomography (NE-CT) scanning images.Materials and methodsThe computed tomography (CT), clinical, and pathological data of 105 BCa patients attending our hospital between January 2017 and August 2022 were retrospectively evaluated. The study cohort comprised 44 low-grade BCa and 61 high-grade BCa patients. The subjects were randomly divided into training (n = 73) and validation (n = 32) cohorts at a ratio of 7:3. Radiomic features were extracted from NE-CT images. A total of 15 representative features were screened using the least absolute shrinkage and selection operator (LASSO) algorithm. Based on these characteristics, six models for predicting BCa pathological grade, including support vector machine (SVM), k-nearest neighbor (KNN), gradient boosting decision tree (GBDT), logical regression (LR), random forest (RF), and extreme gradient boosting (XGBOOST) were constructed. The model combining radiomics score and clinical factors was further constructed. The predictive performance of the models was evaluated based on the area under the receiver operating characteristic (ROC) curve, DeLong test, and decision curve analysis (DCA).ResultsThe selected clinical factors for the model included age and tumor size. LASSO regression analysis identified 15 features most linked to BCa grade, which were included in the machine learning model. The SVM analysis revealed that the highest AUC of the model was 0.842. A nomogram combining the radiomics signature and selected clinical variables showed accurate prediction of the pathological grade of BCa preoperatively. The AUC of the training cohort was 0.919, whereas that of the validation cohort was 0.854. The clinical value of the combined radiomics nomogram was validated using calibration curve and DCA.ConclusionMachine learning models combining CT semantic features and the selected clinical variables can accurately predict the pathological grade of BCa, offering a non-invasive and accurate approach for predicting the pathological grade of BCa preoperatively.
“…Radiomics methods have been widely applied with the extraction of numerous quantitative metrics on the entire tumor from radiological images including CT and MRI 8, 9 . Existing research recognize the critical role of radiomics in re ecting tissue heterogeneity, staging and risk strati cation of TET [10][11][12] . Besides, radiomics has been successfully employed to predict the level of PD-L1 in lung and esophageal tumors 13,14 .…”
Immunotherapy is increasingly being utilized in the management of thymic epithelial tumors (TET). High expression levels of programmed death receptor 1 (PD-1) and its ligand 1 (PD-L1) have been observed in TET, suggesting their potential as prognostic indicators for disease progression and the effectiveness of immunotherapy in TET. We propose that the utilization of quantitative imaging biomarkers could potentially serve as an alternative surrogate for predicting the PD-L1 expression status in clinical decision-making assistance. A total of 124 patients with pathologically confirmed TET (57 PD-L1 positive, 67 PD-L1 negative) were retrospectively enrolled and allocated into training and validation cohorts in a ratio of 7:3. Radiomics features were extracted from T1-weighted, T2-weighted fat suppression, and apparent diffusion coefficient (ADC) map images to establish a radiomics signature in the training cohort. Multivariate logistic regression analysis was conducted to develop a combined radiomics nomogram that incorporated clinical, conventional MR features, or ADC model for evaluation purposes. The performance of each model was compared using receiver operating characteristics analysis, while discrimination, calibration, and clinical efficiency of the combined radiomics nomogram were assessed. The radiomics signature, consisting of four features, demonstrated a favorable ability to predict and differentiate between PD-L1 positive and negative TET patients. The combined radiomics nomogram, which incorporates the peri-cardial invasion sign, ADC value, WHO classification, and radiomics signature, showed excellent performance (training cohort: area under the curve [AUC] = 0.903; validation cohorts: AUC = 0.894). The calibration curve and decision curve analysis further confirmed the clinical usefulness of this combined model. The decision curve analysis demonstrated the clinical utility of the integrated radiomics nomogram. The radiomics signature serves as a valuable tool for predicting the PD-L1 status of TET patients. Furthermore, the integration of radiomics nomogram enhances the personalized prediction capability.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.